Connect your AI

Doximity DOCS Payments to Acquire Intangible Assets

Payments to Acquire Intangible Assets at other companies

Amneal Pharmaceuticals, Inc.AMRX

——

GenpactG

——

Other financials

Income statement

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

Market cap$3.75B-60.5%

Profitability

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's payments to acquire intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Doximity's payments to acquire intangible assets?: Doximity (DOCS) reported payments to acquire intangible assets of $15.5K in Q1 2026.